100 related articles for article (PubMed ID: 11072134)
1. No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3'flanking region of the interleukin-6 gene in patients with multiple sclerosis.
Schmidt S; Papassotiropoulos A; Bagli M; Harzheim M; Heun R; Klockgether T
Neurosci Lett; 2000 Nov; 294(3):139-42. PubMed ID: 11072134
[TBL] [Abstract][Full Text] [Related]
2. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.
Padberg F; Feneberg W; Schmidt S; Schwarz MJ; Körschenhausen D; Greenberg BD; Nolde T; Müller N; Trapmann H; König N; Möller HJ; Hampel H
J Neuroimmunol; 1999 Oct; 99(2):218-23. PubMed ID: 10505978
[TBL] [Abstract][Full Text] [Related]
3. Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis.
Schmidt S; Papassotiropoulos A; Sotgiu S; Kölsch H; Arru G; Fois ML; Haase CG; Schmitz S; König N; Harzheim M; Heun R; Klockgether T
J Neurol; 2003 May; 250(5):607-11. PubMed ID: 12736743
[TBL] [Abstract][Full Text] [Related]
4. Multiple levels of regulation of the interleukin-6 system in stroke.
Acalovschi D; Wiest T; Hartmann M; Farahmi M; Mansmann U; Auffarth GU; Grau AJ; Green FR; Grond-Ginsbach C; Schwaninger M
Stroke; 2003 Aug; 34(8):1864-9. PubMed ID: 12843357
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
[TBL] [Abstract][Full Text] [Related]
6. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters?
Kovacs E; Kuehn JJ
Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
[TBL] [Abstract][Full Text] [Related]
9. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
Weiss TW; Arnesen H; Seljeflot I
Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306
[TBL] [Abstract][Full Text] [Related]
10. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
[TBL] [Abstract][Full Text] [Related]
12. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
13. A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects.
Rafiq S; Frayling TM; Murray A; Hurst A; Stevens K; Weedon MN; Henley W; Ferrucci L; Bandinelli S; Corsi AM; Guralnik JM; Melzer D
Genes Immun; 2007 Oct; 8(7):552-9. PubMed ID: 17671508
[TBL] [Abstract][Full Text] [Related]
14. High circulating levels of biologically inactive IL-6/SIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130.
Pignatti P; Ciapponi L; Galle P; Hansen MB; Massa M; Meazza C; Paonessa G; Novick D; Ciliberto G; Martini A; De Benedetti F
Clin Exp Immunol; 2003 Feb; 131(2):355-63. PubMed ID: 12562400
[TBL] [Abstract][Full Text] [Related]
15. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
Li Y; Wang Y; Qi L
Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537
[TBL] [Abstract][Full Text] [Related]
16. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure.
Hirota H; Izumi M; Hamaguchi T; Sugiyama S; Murakami E; Kunisada K; Fujio Y; Oshima Y; Nakaoka Y; Yamauchi-Takihara K
Heart Vessels; 2004 Sep; 19(5):237-41. PubMed ID: 15372299
[TBL] [Abstract][Full Text] [Related]
17. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.
Wonnerth A; Katsaros KM; Krychtiuk KA; Speidl WS; Kaun C; Thaler K; Huber K; Wojta J; Maurer G; Seljeflot I; Arnesen H; Weiss TW
Metabolism; 2014 May; 63(5):647-53. PubMed ID: 24629561
[TBL] [Abstract][Full Text] [Related]
19. Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange.
Tesar V; Jelínková E; Jirsa M; Bakosová M; Pitha P; Chábová V
Blood Purif; 2000; 18(2):115-20. PubMed ID: 10838470
[TBL] [Abstract][Full Text] [Related]
20. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
Simpson KJ; Jones AL; Forbes Howie A; Hayes PC
Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
